A Second Career As A Biotech CEO
It’s not surprising that Steven Yatomi-Clarke started his second career at a company named Prescient...
It’s not surprising that Steven Yatomi-Clarke started his second career at a company named Prescient...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.